Continuous Glucose Monitoring Device Market Share, Size, Trends, Industry Analysis Report, By Component Type (Transmitters & Receivers, Sensors, and Insulin Pumps); By End-Use; By Region; Segment Forecast, 2023 - 2032
Description
Continuous Glucose Monitoring Device Market Share, Size, Trends, Industry Analysis Report, By Component Type (Transmitters & Receivers, Sensors, and Insulin Pumps); By End-Use; By Region; Segment Forecast, 2023 - 2032
The global continuous glucose monitoring device market size is expected to reach USD 54,735.48 million by 2032, according to a new study by Polaris Market Research. The report “Continuous Glucose Monitoring Device Market Share, Size, Trends, Industry Analysis Report, By Component Type (Transmitters & Receivers, Sensors, and Insulin Pumps); By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global market for continuous glucose monitoring (CGM) devices has experienced a surge in demand due to the impact of the COVID-19 pandemic. The increased risks of hospitalization for diabetes patients during the pandemic have prompted governments and regulatory bodies to expand the availability of noninvasive glucose monitoring devices, particularly in hospitals. This has resulted in a significant rise in the usage of CGM devices in healthcare settings, including intensive care units (ICUs), as they allow for continuous monitoring without direct patient contact.
CGM devices are wearable technologies that provide valuable assistance to both type-1 and type-2 diabetes patients by reducing the need for frequent fingerstick tests. These devices track glucose levels continuously through smartphone apps, delivering readings every few minutes throughout the day. Utilizing wireless transmitters, they transmit glucose data from the sensor to a receiver, enabling real-time monitoring and data analysis.
Governments worldwide have launched programs to promote the adoption of CGM devices, focusing on educating diabetes patients and healthcare providers. For instance, the German government offers training programs such as Flash and Spectrum, conducted by Diabetes Care and Education Specialists, to educate patients and healthcare professionals on the effective use of continuous glucose monitoring devices. Similarly, in Korea, a study conducted by the Korean Association of Diabetes Nurse Educators demonstrated that educational programs on CGM device usage have led to increased adoption rates.
Continuous Glucose Monitoring Device Market Report Highlights
The sensor segment is anticipated to witness significant growth during the forecast period as technological advancements and the short lifespan of sensors are driving growth.
Homecare diagnostics, the largest segment, is expected to maintain dominance due to awareness, convenience, rising income, and COVID-19 concerns in hospitals.
North America is set to dominate the continuous glucose monitoring device market due to a high prevalence of diabetes and supportive factors.
The global key market players include A. Menarini Diagnostics, Echo Therapeutics, Inc., Abbott Laboratories, Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, GlySens Incorporated, Insulet Corporation, Johnson & Johnson, LifeScan, Medtronic plc, Medtrum Technologies, Inc., Microchip Technology Inc., Micron Technology Inc., Nemaura Medical, Inc., Novo Nordisk, NXP Semiconductors, Qualcomm, Roche Diagnostics, Senseonics Holdings, Inc., STMicroelectronics, and Tandem Diabetes Care.
Polaris Market Research has segmented the continuous glucose monitoring device market report based on component type, end-use, and region:
Continuous Glucose Monitoring Device, Component Type Outlook (Revenue - USD Million, Volume – Million Units, 2019 - 2032)
Transmitters & Receivers
Sensors
Insulin Pumps
Continuous Glucose Monitoring Device, End-Use Outlook (Revenue - USD Million, Volume – Million Units, 2019 - 2032)
Hospitals
Homecare Diagnostics
Others
Continuous Glucose Monitoring Device, Regional Outlook (Revenue - USD Million, Volume – Million Units, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
119 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Continuous Glucose Monitoring Device Market Insights
- 4.1. Continuous Glucose Monitoring Device Market – Industry Snapshot
- 4.2. Continuous Glucose Monitoring Device Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological advancements improve diabetes management.
- 4.2.1.2. Rising Prevalence of Diabetes
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Continuous Glucose Monitoring Device Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Continuous Glucose Monitoring Device Market, by Component Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Continuous Glucose Monitoring Device, by Component Type, 2019-2032 (USD Million)
- 5.3. Transmitters & Receivers
- 5.3.1. Global Continuous Glucose Monitoring Device Market, by Transmitters & Receivers, by Region, 2019-2032 (USD Million)
- 5.4. Sensors
- 5.4.1. Global Continuous Glucose Monitoring Device Market, by Sensors, by Region, 2019-2032 (USD Million)
- 5.5. Insulin Pumps
- 5.5.1. Global Continuous Glucose Monitoring Device Market, by Insulin Pumps, by Region, 2019-2032 (USD Million)
- 6. Global Continuous Glucose Monitoring Device Market, by End-Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Continuous Glucose Monitoring Device Market, by Hospitals, by Region, 2019-2032 (USD Million)
- 6.4. Homecare Diagnostics
- 6.4.1. Global Continuous Glucose Monitoring Device Market, by Homecare Diagnostics, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Continuous Glucose Monitoring Device Market, by Others, by Region, 2019-2032 (USD Million)
- 7. Global Continuous Glucose Monitoring Device Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Continuous Glucose Monitoring Device Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Continuous Glucose Monitoring Device Market – North America
- 7.3.1. North America: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.3.2. North America: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.3.3. Continuous Glucose Monitoring Device Market – U.S.
- 7.3.3.1. U.S.: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.3.4. Continuous Glucose Monitoring Device Market – Canada
- 7.3.4.1. Canada: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4. Continuous Glucose Monitoring Device Market – Europe
- 7.4.1. Europe: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.2. Europe: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.3. Continuous Glucose Monitoring Device Market – UK
- 7.4.3.1. UK: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.3.2. UK: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.4. Continuous Glucose Monitoring Device Market – France
- 7.4.4.1. France: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.4.2. France: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.5. Continuous Glucose Monitoring Device Market – Germany
- 7.4.5.1. Germany: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.6. Continuous Glucose Monitoring Device Market – Italy
- 7.4.6.1. Italy: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.7. Continuous Glucose Monitoring Device Market – Spain
- 7.4.7.1. Spain: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.8. Continuous Glucose Monitoring Device Market – Netherlands
- 7.4.8.1. Netherlands: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.4.9. Continuous Glucose Monitoring Device Market – Russia
- 7.4.9.1. Russia: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5. Continuous Glucose Monitoring Device Market – Asia Pacific
- 7.5.1. Asia Pacific: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.3. Continuous Glucose Monitoring Device Market – China
- 7.5.3.1. China: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.3.2. China: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.4. Continuous Glucose Monitoring Device Market – India
- 7.5.4.1. India: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.4.2. India: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.5. Continuous Glucose Monitoring Device Market – Malaysia
- 7.5.5.1. Malaysia: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.6. Continuous Glucose Monitoring Device Market – Japan
- 7.5.6.1. Japan: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.7. Continuous Glucose Monitoring Device Market – Indonesia
- 7.5.7.1. Indonesia: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.5.8. Continuous Glucose Monitoring Device Market – South Korea
- 7.5.8.1. South Korea: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.6. Continuous Glucose Monitoring Device Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.6.3. Continuous Glucose Monitoring Device Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.6.4. Continuous Glucose Monitoring Device Market – UAE
- 7.6.4.1. UAE: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.6.5. Continuous Glucose Monitoring Device Market – Israel
- 7.6.5.1. Israel: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.6.6. Continuous Glucose Monitoring Device Market – South Africa
- 7.6.6.1. South Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.7. Continuous Glucose Monitoring Device Market – Latin America
- 7.7.1. Latin America: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.7.2. Latin America: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.7.3. Continuous Glucose Monitoring Device Market – Mexico
- 7.7.3.1. Mexico: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.7.4. Continuous Glucose Monitoring Device Market – Brazil
- 7.7.4.1. Brazil: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 7.7.5. Continuous Glucose Monitoring Device Market – Argentina
- 7.7.5.1. Argentina: Continuous Glucose Monitoring Device Market, by End-Use, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Continuous Glucose Monitoring Device Market, by Component Type, 2019-2032 (USD Million)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. A. Menarini Diagnostics
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Echo Therapeutics, Inc
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Abbott Laboratories
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Bayer AG
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Dexcom, Inc
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6.F. Hoffmann-La Roche Ltd
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. GE Healthcare
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. GlySens Incorporated
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Insulet Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Johnson & Johnson
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. LifeScan
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Medtronic plc
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Medtrum Technologies, Inc
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Microchip Technology Inc
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Micron Technology Inc
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16.Nemaura Medical, Inc
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
- 9.17. Novo Nordisk
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
- 9.18. NXP Semiconductors
- 9.18.1. Company Overview
- 9.18.2. Financial Performance
- 9.18.3. Product Benchmarking
- 9.18.4. Recent Development
- 9.19. Qualcomm
- 9.19.1. Company Overview
- 9.19.2. Financial Performance
- 9.19.3. Product Benchmarking
- 9.19.4. Recent Development
- 9.20. Roche Diagnostics
- 9.20.1. Company Overview
- 9.20.2. Financial Performance
- 9.20.3. Product Benchmarking
- 9.20.4. Recent Development
- 9.21. Senseonics Holdings, Inc
- 9.21.1. Company Overview
- 9.21.2. Financial Performance
- 9.21.3. Product Benchmarking
- 9.21.4. Recent Development
- 9.22. STMicroelectronics
- 9.22.1. Company Overview
- 9.22.2. Financial Performance
- 9.22.3. Product Benchmarking
- 9.22.4. Recent Development
- 9.23. Tandem Diabetes Care
- 9.23.1. Company Overview
- 9.23.2. Financial Performance
- 9.23.3. Product Benchmarking
- 9.23.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
